What is the equity of Amedisys this year?
Amedisys has equity of 1.07 B USD this year.
Amedisys Equity 2024
Amedisys Equity
1.07 B USD
Ticker
AMED
ISIN
US0234361089
WKN
915582
In 2024, Amedisys's equity was 1.07 B USD, a 1.42% increase from the 1.05 B USD equity in the previous year.
Amedisys Aktienanalyse
What does Amedisys do?
Amedisys Inc is a US home healthcare provider that offers a variety of healthcare services in the private home, including home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. The company was founded in 1982 by William F. Borne and Michael J. Borne and is headquartered in Baton Rouge, Louisiana. History In the 1980s, while William and Michael Borne were running a nursing home together, they recognized a demand for home healthcare and founded Amedisys in 1982. The company started with a small group of nurses making house calls and was based on the belief that people would prefer to be cared for at home rather than being placed in a facility. In 1999, Amedisys was acquired by the American Stock Exchange and was able to steadily improve its performance and expand its business model to multiple states. In 2007, the company went public and has been listed on NASDAQ since. Business Model Amedisys offers a wide range of healthcare services that are typically received by patients at home. The services include home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. Amedisys collaborates with over 360 medical faculties and over 7,500 medical professionals who provide healthcare to over 385,000 patients per year. Amedisys also offers training programs for nurses and other employees to discover the business and potential growth opportunities. The company relies on teamwork to motivate staff and keep their knowledge and skills up-to-date. Segments Amedisys operates in two main business segments: home healthcare and hospice care. Both segments offer specialized services and are provided by professionals such as registered nurses, therapists, medical assistants, and social workers. The company has more than 435 hospice facilities in 34 US states and over 197 home healthcare branches in 38 US states. Products Amedisys offers a variety of products, including infusion therapy, professional wound management, clinical respiratory therapy, polypharmacy management, specialized care services, and palliative care. The company also provides telemedicine options for patients to receive care from home. Summary Amedisys is a leading provider of home healthcare and hospice care in the US. The company offers a wide range of services and is able to serve both the inpatient and outpatient settings. The company relies on teamwork to provide comprehensive and high-quality care to patients. Amedisys is a successful and expanding company that is also exploring new market potentials through the use of technology. Amedisys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Amedisys's Equity
Amedisys's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Amedisys's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Amedisys's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Amedisys's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Amedisys’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Amedisys Stock
What was the equity of Amedisys compared to the previous year?
The equity of Amedisys has increased/decreased by 1.42% increased compared to the previous year.
What impact does a high equity have on investors of Amedisys?
A high equity is advantageous for investors of Amedisys as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Amedisys?
A low equity can be a risk for investors of Amedisys, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Amedisys affect the company?
An increase in equity of Amedisys can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Amedisys affect the company?
A reduction in equity of Amedisys can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Amedisys?
Some factors that can affect the equity of Amedisys include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Amedisys so important for investors?
The equity of Amedisys is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Amedisys take to change the equity?
To change equity, Amedisys can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Amedisys pay?
Over the past 12 months, Amedisys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amedisys is expected to pay a dividend of 0 USD.
What is the dividend yield of Amedisys?
The current dividend yield of Amedisys is .
When does Amedisys pay dividends?
Amedisys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Amedisys?
Amedisys paid dividends every year for the past 0 years.
What is the dividend of Amedisys?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Amedisys located?
Amedisys is assigned to the 'Health' sector.
Wann musste ich die Aktien von Amedisys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Amedisys from 6/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.
When did Amedisys pay the last dividend?
The last dividend was paid out on 6/26/2024.
What was the dividend of Amedisys in the year 2023?
In the year 2023, Amedisys distributed 0 USD as dividends.
In which currency does Amedisys pay out the dividend?
The dividends of Amedisys are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Amedisys stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Amedisys
Our stock analysis for Amedisys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amedisys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
